The role of ayurveda and the need for a national ayush cancer care grid in integrative oncology

Cancer continues to pose a significant global health challenge, characterized by increasing incidence rates, substantial mortality, and considerable effects on patient quality of life. Despite advancements in modern oncology, including chemotherapy, radiotherapy, targeted therapies, and immunotherapies, treatment-related toxicities and enduring physiological and psychological burdens remain prevalent. Ayurveda provides a complementary framework that focuses on individualized care, detoxification, immune restoration, and long-term resilience within a holistic system. The integration of Ayurveda and modern oncology presents an opportunity to enhance cancer care. However, this potential can only be achieved through the generation of substantial evidence and the establishment of collaborative clinical networks. Classical Ayurvedic literature delineates tumor-like conditions, including Granthi (benign swellings) and Arbuda (malignant growths), with specific entities such as adhyarbuda and dwirarbuda, which correspond to contemporary cancer classifications. Ayurvedic pathology, based on the principles of Tridosha imbalance and Dhatu dushti, assists practitioners in evaluating disease prognosis, Sadhya, Yapya, or Asadhya, and in formulating personalized therapeutic strategies. The primary treatment modalities include Shodhana (purification), Shamana (palliation), and Rasayana (rejuvenation), complemented by lifestyle interventions, yoga, pranayama, and customized dietary plans. These approaches may enhance active oncology treatment by alleviating toxicities associated with chemotherapy and radiotherapy, decreasing oxidative stress, bolstering immunity, and improving tolerance and functional well-being. Despite the increasing interest in integrative oncology, the Ayush sector encounters a significant obstacle: the absence of standardized, large-scale clinical evidence. In India, various practitioners involved in Ayurvedic oncology, research, and academic institutions operate independently, leading to fragmented data and insufficient clinical documentation. The current requirement for evidence-based validation for mainstream acceptance limits the integration of Ayurveda into cancer care pathways due to fragmentation. A unified national Ayush Cancer Care Grid is essential to address this gap. Inspired by the achievements of the National Cancer Grid, this platform aims to unite practitioners, researchers, institutions, and educators with a common objective of standardization, collaboration, and evidence generation, along with better patient care. A grid indicates a general intent to collaborate, whereas a grid signifies organized, coordinated efforts with a specific public health objective aligning clinical practices, minimizing disparities, and promoting multicentric research. A DEDICATED AYUSH CANCER CARE GRID WOULD FACILITATE A centralized data repository for documenting clinical outcomes, therapeutic protocols, Ayurveda medicine interventions, safety profiles, and long-term follow-up Standardized case record formats and validated integrative treatment protocols enhance consistency among practitioners and institutions Collaborative research initiatives encompass observational studies, Ayurvedic intervention trials, and translational research that connects traditional concepts with contemporary biomarkers Expert consultations and virtual boards facilitate access to specialized integrative guidance for complex cancer cases Capacity building is facilitated through continuing medical education programs, workshops, and national and international seminars, thereby ensuring ongoing professional development Initiatives aimed at increasing awareness of safe, evidence-based integrative oncology practices. The initial establishment and operational framework for this grid can be developed with minimal financial investment by utilizing digital platforms, encouraging voluntary participation, and fostering institutional partnerships to generate momentum and trust. The future of integrative oncology necessitates collaboration rather than isolation. Establishing a structured, collaborative Ayush Cancer Care Grid presents India with the potential to produce credible, multicentric evidence, standardize clinical best practices, and enhance Ayurveda’s status as a scientifically validated, globally pertinent contributor to cancer care. It is an opportune moment to transition from fragmented initiatives to a cohesive national movement that recognizes Ayurveda as an essential element in a humane, patient-centered, and integrative oncology framework.